Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026 - Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 20 February 2026 - Oil and Natural Gas Corporation (ONGC) and RBL Bank shares - and has suggested selling Info Edge (India) stock futures.
Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5840 in its research report dated May 28, 2026.
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Neutral Lupin; target of Rs 2520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2520 in its research report dated May 10, 2026.
Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June
Stocks to Watch, 09 June: Stocks like NLC India, IRB Infrastructure Developers, Panacea Biotec, Grasim Industries, HCL Technologies, Rail Vikas Nigam, JNK India, Motilal Oswal Financial Services, and NRB Bearings will be in focus on June 9.
HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings
Motilal Oswal Healthcare Foundation, and Motilal Oswal Foundation were sellers in Motilal Oswal Financial Services shares.
Max Healthcare shares fall up to 7% as Q4 results miss estimates
Analysts at domestic brokerage Motilal Oswal Financial Services said the earnings miss was due to a higher tax rate .